PTEN and head and neck squamous cell carcinoma: Not surprisingly, genetic alteration in PIK3CA, HRAS, PTEN, and other agents which results in PI3K-mTOR pathway activation were identified in those panels, consistent with the HNSCC genomic landscape described above.